Literature DB >> 9078247

Involvement of two basic residues (Lys-270 and Arg-276) of human liver 3 alpha-hydroxysteroid dehydrogenase in NADP(H) binding and activation by sulphobromophthalein: site-directed mutagenesis and kinetic analysis.

K Matsuura1, Y Tamada, K Sato, H Iwasa, G Miwa, Y Deyashiki, A Hara.   

Abstract

A human liver 3 alpha-hydroxysteroid dehydrogenase isoenzyme, a member of the aldo-keto reductase family, shows a marked preference for NADP(H) over NAD(H), and is activated by sulphobromophthalein, which increases the Km values for both NADP(H) and substrates. Here we report kinetic alterations in binding of the coenzymes and the activator to the enzyme caused by site-directed mutagenesis of Lys-270 and Arg-276, which are strictly conserved among the aldo-keto reductase family of enzymes. The mutated enzymes, K270M and R276M, showed increases in the Km for NADP+ of 22- and 290-fold respectively; the Km for alcohol substrate and the kca1 of the NADP(-)-linked reaction were also elevated, by 9- and 5-fold respectively. No kinetic constant of the NAD(+)-linked reaction was altered by more than 3-fold. Calculation of the free-energy changes showed that the 2'-phosphate group of NADP+ contributes 16.3 kJ/mol (3.9 kcal/mol) of binding energy to its interaction with the wildtype enzyme, and the mutagenesis to K270M and R276M destabilized the binding energy of NADP+ by 6.3 and 13.0 kJ/mol (1.5 and 3.1 kcal/mol) respectively. In addition, the mutations attenuated enzyme activation by sulphobromophthalein, which bound to the mutant enzymes as an inhibitor. The inhibition for the R276M mutant was competitive with respect to NADP+ and non-competitive with respect to the substrate, whereas that for the K270M mutant was mixed-type, showing activation at coenzyme concentrations greater than 20 x Km. These results suggest that the two basic residues in the 3 alpha-hydroxysteroid dehydrogenase isoenzyme play crucial roles in binding both the negatively charged 2'-phosphate group of NADP+ and the sulphonic groups of sulphobromophthalein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9078247      PMCID: PMC1218162          DOI: 10.1042/bj3220089

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Structural and functional comparison of two human liver dihydrodiol dehydrogenases associated with 3 alpha-hydroxysteroid dehydrogenase activity.

Authors:  Y Deyashiki; H Taniguchi; T Amano; T Nakayama; A Hara; H Sawada
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

4.  Purification of 3 alpha-hydroxysteroid and 3 beta-hydroxysteroid dehydrogenases from human liver cytosol.

Authors:  H Takikawa; M Fujiyoshi; K Nishikawa; M Yamanaka
Journal:  Hepatology       Date:  1992-08       Impact factor: 17.425

5.  Purification and properties of multiple forms of dihydrodiol dehydrogenase from human liver.

Authors:  A Hara; H Taniguchi; T Nakayama; H Sawada
Journal:  J Biochem       Date:  1990-08       Impact factor: 3.387

6.  An unlikely sugar substrate site in the 1.65 A structure of the human aldose reductase holoenzyme implicated in diabetic complications.

Authors:  D K Wilson; K M Bohren; K H Gabbay; F A Quiocho
Journal:  Science       Date:  1992-07-03       Impact factor: 47.728

7.  Isolation and characterization of cloned cDNAs encoding human liver chlordecone reductase.

Authors:  C J Winters; D T Molowa; P S Guzelian
Journal:  Biochemistry       Date:  1990-01-30       Impact factor: 3.162

8.  Isolation of proteins with carbonyl reductase activity and prostaglandin-9-ketoreductase activity from chicken kidney.

Authors:  A Hara; Y Deyashiki; M Nakagawa; T Nakayama; H Sawada
Journal:  J Biochem       Date:  1982-12       Impact factor: 3.387

9.  The aldo-keto reductase superfamily. cDNAs and deduced amino acid sequences of human aldehyde and aldose reductases.

Authors:  K M Bohren; B Bullock; B Wermuth; K H Gabbay
Journal:  J Biol Chem       Date:  1989-06-05       Impact factor: 5.157

10.  Expression of human aldose and aldehyde reductases. Site-directed mutagenesis of a critical lysine 262.

Authors:  K M Bohren; J L Page; R Shankar; S P Henry; K H Gabbay
Journal:  J Biol Chem       Date:  1991-12-15       Impact factor: 5.157

View more
  5 in total

1.  Kinetic alteration of a human dihydrodiol/3alpha-hydroxysteroid dehydrogenase isoenzyme, AKR1C4, by replacement of histidine-216 with tyrosine or phenylalanine.

Authors:  T Ohta; S Ishikura; S Shintani; N Usami; A Hara
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

2.  Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes.

Authors:  L D Griffin; S H Mellon
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

3.  Structure of xylose reductase bound to NAD+ and the basis for single and dual co-substrate specificity in family 2 aldo-keto reductases.

Authors:  Kathryn L Kavanagh; Mario Klimacek; Bernd Nidetzky; David K Wilson
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

4.  Roles of the C-terminal domains of human dihydrodiol dehydrogenase isoforms in the binding of substrates and modulators: probing with chimaeric enzymes.

Authors:  K Matsuura; A Hara; Y Deyashiki; H Iwasa; T Kume; S Ishikura; H Shiraishi; Y Katagiri
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

5.  The coenzyme specificity of Candida tenuis xylose reductase (AKR2B5) explored by site-directed mutagenesis and X-ray crystallography.

Authors:  Barbara Petschacher; Stefan Leitgeb; Kathryn L Kavanagh; David K Wilson; Bernd Nidetzky
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.